O-6-methylguanine-DNA methyltransferase mRNA (MGMT mRNA) (MGMT mRNA)

O-6-methylguanine-DNA methyltransferase (MGMT) mRNA is the transcript encoding the MGMT protein, a crucial suicide enzyme involved in direct DNA repair (Source: UniProt P16455). The protein product removes alkyl groups from the O6 position of guanine, a common site of damage by alkylating chemotherapeutic agents like temozolomide (Source: PubMed PMID: 29334363). In clinical oncology, MGMT mRNA levels are highly correlated with resistance to chemotherapy; high expression allows tumor cells to repair drug-induced DNA lesions, while low expression—often due to promoter methylation—sensitizes them (Source: PubMed PMID: 15758003). Targeting MGMT mRNA using antisense oligonucleotides (ASOs) or RNA interference (RNAi) represents a strategy to deplete the protein reservoir and overcome chemoresistance in aggressive cancers like glioblastoma (Source: PubMed PMID: 11507054). Beyond its role in resistance, MGMT mRNA expression serves as a vital predictive biomarker for patient stratification in clinical trials (Source: PubMed PMID: 25135958). The inhibition of this pathway is particularly relevant in glioblastoma multiforme, where MGMT status determines the efficacy of the standard-of-care Stupp protocol. Experimental therapies aim to transiently silence MGMT mRNA to create a therapeutic window for alkylating agents while minimizing long-term genomic instability. Monitoring MGMT mRNA levels provides a more direct measure of potential enzyme activity compared to DNA methylation status alone in certain tumor types.

Other names

O6-methylguanine-DNA methyltransferase mRNAMGMT transcriptMethylguanine-DNA methyltransferase mRNA

The primary mechanism of action for drugs targeting MGMT mRNA involves the use of antisense oligonucleotides or siRNA to trigger the degradation of the transcript via RNase H or the RNA-induced silencing complex (RISC), thereby preventing the translation of the MGMT protein (Source: PubMed PMID: 11507054). By reducing MGMT protein levels, these agents inhibit the repair of O6-methylguanine adducts, facilitating the formation of lethal DNA cross-links by alkylating agents (Source: PubMed PMID: 29334363).